# Boehringer Ingelheim expands Fremont biologics facility with $217M

Boehringer Ingelheim broke ground on a $217 million expansion of its Fremont, California manufacturing facility. The expansion will triple capacity and add nearly 300 new jobs.

- Type: Expansion
- Announced: 2017-07-01
- Where: Fremont, California, United States
- Value: $217.0M
- Jobs: 300
- Starts operating: 2018
- Status: under construction
- Capacity: increase manufacturing capacity by one-third
- Products: human biologics medicines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boehringer Ingelheim](https://endata.com/companies/25171.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/boehringer-ingelheim-breaks-ground-on-217-million-expansion-of-fremont-california-manufacturing-facility-300492417.html), 2017-07-21: "This significant expansion will enable the company to increase its manufacturing capacity by one-third"
- [biopharmadive.com](https://www.biopharmadive.com/news/boehringer-manufacturing-expansion-fremont-california/447938/), 2017-07-26: "California granted Boehringer two tax credits awards totaling $25.5 million for the build-out."
- [pharmaceutical-technology.com](https://www.pharmaceutical-technology.com/projects/boehringer-ingelheim-expansion-fremont/), 2017-11-13: "The expansion is expected to increase the facility’s manufacturing capacity by a third upon completion by 2018."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.